(18)F-labelled cardiac PET tracers: selected probes for the molecular imaging of transporters, receptors and proteases
- PMID: 18324369
- DOI: 10.1007/s00395-008-0703-6
(18)F-labelled cardiac PET tracers: selected probes for the molecular imaging of transporters, receptors and proteases
Abstract
Designated radiopharmaceuticals labelled with the prominent positron-emitter (18)F can be defined as molecular imaging probes for the examination of cardiovascular diseases at the cellular and subcellular level. Such molecular imaging agents representing radioindicators or radiotracers offer the opportunity to non-invasively trace their path and fate in the living organism by the scintigraphic technique, positron emission tomography (PET). The glucose analogue [(18)F]FDG is a widespread PET tracer and one of the earliest examples of a PET molecular imaging probe feasible to in vivo visualise glucose utilisation by a metabolic trapping mechanism. This short review is focussed on selected established (18)F-labelled PET tracers as well as (18)F-labelled radioligands in development that show the potential of being probes for the in vivo molecular imaging of proteins relevant in cardiovascular diseases such as receptors (i.e. beta-Adrenoceptors), transporters (i.e. NET and VMAT) and proteases (i.e. MMPs).
Similar articles
-
Non-peptidyl (18)F-labelled PET tracers as radioindicators for the noninvasive detection of cancer.Recent Results Cancer Res. 2013;187:107-32. doi: 10.1007/978-3-642-10853-2_3. Recent Results Cancer Res. 2013. PMID: 23179879 Review.
-
Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.Coron Artery Dis. 2001 Feb;12 Suppl 1:S12-8. Coron Artery Dis. 2001. PMID: 11286301 Review.
-
Myocardial distribution of (18)F-FDG and (99m)Tc-sestamibi on dual-isotope simultaneous acquisition SPET compared with PET.Eur J Nucl Med Mol Imaging. 2002 Oct;29(10):1357-64. doi: 10.1007/s00259-002-0889-z. Epub 2002 Jul 23. Eur J Nucl Med Mol Imaging. 2002. PMID: 12271419 Clinical Trial.
-
Radioligands for imaging myocardial alpha- and beta-adrenoceptors.Nuklearmedizin. 2003 Feb;42(1):4-9. Nuklearmedizin. 2003. PMID: 12601447 Review.
-
Oncologic PET tracers beyond [(18)F]FDG and the novel quantitative approaches in PET imaging.Q J Nucl Med Mol Imaging. 2008 Mar;52(1):50-65. Q J Nucl Med Mol Imaging. 2008. PMID: 18235421 Review.
Cited by
-
Synthesis and Cardiac Imaging of (18)F-Ligands Selective for β1-Adrenoreceptors.ACS Med Chem Lett. 2011 Jul 22;2(9):650-5. doi: 10.1021/ml1002458. eCollection 2011 Sep 8. ACS Med Chem Lett. 2011. PMID: 24900360 Free PMC article.
-
Nanomedicine--challenge and perspectives.Angew Chem Int Ed Engl. 2009;48(5):872-97. doi: 10.1002/anie.200802585. Angew Chem Int Ed Engl. 2009. PMID: 19142939 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources